Excecutive Team
Medical Advisory Board Members
Y. Ralph Chu, MD
Chu Vision Institute
Dr. Chu is the founder and medical director of Chu Vision Institute and Chu Surgery Center. Dr. Chu performs over 1,000 surgeries a year, delivering customization technologies to all his patients. He is an international leader in refractive and cataract surgery, lecturing and teaching physicians on cataract and intraocular lens implantations, phakic lens implantation, laser vision correction technologies and ocular therapeutic treatments on almost every continent. He opened Chu Vision Institute in 1999 and in 2007 expanded his practice to meet the increasing needs for cataract surgery. He has been honored by selection to the editorial board of Cataract and Refractive Surgery Today, Review of Ophthalmology, EyeWorld and Refractive Eye Care.
David F. Chang, MD
University of California, San Francisco
Dr. Chang is a Summa Cum Laude graduate of Harvard College and Harvard Medical School. He completed his ophthalmology residency at the University of California, San Francisco where he is now a clinical professor. Having chaired the ASCRS Cataract Clinical Committee, Dr. Chang has been on the ASCRS Board and Executive Committee since 2009 and served as the 2012-2013 president. He is past chair of the AAO Cataract Preferred Practice Pattern Panel and in 2009 completed his 5-year term as chair of the AAO Annual Meeting Program Committee. Dr. Chang also co-chairs the ASCRS Foundation and serves on the medical advisory boards of Himalayan Cataract Project and Project Vision. He served as chief medical editor of EyeWorld, and Cataract and Refractive Surgery Today. In 2018, he was voted the 5th most influential ophthalmologist in the world by the international readership of The Ophthalmologist.
In 2006, Dr. Chang became only the third ophthalmologist to ever receive the Charlotte Baer Award which annually honors the outstanding clinical faculty member at the UCSF Medical School. He has received the highest honor for cataract surgery or for an international ophthalmologist from the following organizations: ASCRS (Binkhorst Medal), AAO (Kelman Lecture), Asia Pacific Association of Cataract & Refractive Surgery (Lim Medal), United Kingdom and Ireland Society of Cataract & Refractive Surgery (Rayner Medal), Canadian Society of Cataract and Refractive Surgery (Award of Excellence/Stein Lecture), All India Ophthalmology Society (President's Lecture), Indian Intraocular Implant & Refractive Society (Gold Medal), Italian Ophthalmological Society (Strampelli Medal), International Intraocular Implant Club (IIIC Medal), American-European Congress of Ophthalmic Surgery (Visionary Award), Royal Australia and New Zealand College of Ophthalmologists (Gregg Medal), and the Asia-Pacific Academy of Ophthalmology (Jose Rizal International Medal). Including these, Dr. Chang has delivered a total of 39 named lectures.
Jason Jones, MD
Jones Eye Clinic
Dr. Jones completed his undergraduate degree from Harvard College, graduating magna cum laude. He obtained his medical degree from New York University, followed by internship in Medicine and Ophthalmology at the University of Utah. Dr. Jones' practice interests include advanced cataract extraction techniques, new IOL technologies and novel prosthetic devices designed to assist complicated or unusual cataract surgeries. Dr. Jones is an expertise in clinical and surgical management of glaucoma.
Sean Ianchulev, MD
Ophthalmic Innovation and Technology
Dr. Ianchulev is a Professor of Ophthalmology at the New York Eye and Ear Infirmary of Mount Sinai and Director of Ophthalmic Innovation and Technology. As an inventor, researcher and developer, he is one of the top innovators in the field - his breakthrough research and inventions have resulted in major advances in ophthalmology, which have transformed the treatment paradigms in retina, glaucoma and have led to new FDA approved therapies benefiting hundreds of thousands of patients every year. Dr. Ianchulev was the principal scientist who designed and lead the clinical research of Lucentis - the first antibody therapy in ophthalmology for the treatment of wet AMD, diabetic macular edema, and retinal vein occlusions. He is also the inventor of intraoperative aberrometry - the advanced biometry surgical guidance system for high precision cataract surgery. He lead the development of the CyPass micro-stent - the first MIGS supraciliary implant to receive FDA approval. Dr. Ianchulev is also the founder of a new technology for micro-interventional cataract surgery (miLOOP, Iantech, Inc), as well as the specialty biopharma Eyenovia, Inc, which is developing new therapeutic approaches for front-of-the-eye disease. His milestone publications have been cited by more than 2,000 peer-review papers. Dr. Ianchulev is an invited speaker at many international meetings and panels and has been an invited expert by the US Congress on matters on policies related to healthcare, technology and innovation.
Doug Koch, MD
Jamail Specialty Care Center - Alkek Eye Center
Dr. Koch graduated from Harvard Medical School in 1977 and has been practicing for 38 years. He is past president of American Society of Cataract and Refractive Surgery, the American Ophthalmological Society, and the International Intra-Ocular Implant Club. He has given over 30 named lectures, including the Kelman, Binkhorst, and Barraquer Lectures at the AAO Annual Meeting; the Charles Kelman Innovators Lecture at the 2012 annual meeting of ASCRS; and the Binkhorst Medal Lecture at the 2013 annual meeting of ESCRS. His work focuses on management of complications of cataract and intraocular lens problems, iris repair and replacement, and improving the outcomes of cataract and refractive surgery procedures such as LASIK and PRK. Dr. Koch is a pioneer in this field, conducting research and teaching physicians all around the world.
Susan MacDonald, MD
Lahey Clinic Medical Center
Dr. Susan MacDonald is an Associate Professor Tufts School of Medicine and the Director of Comprehensive Ophthalmology at the Lahey Clinic Medical Center. She received her medical degree from University of Massachusetts Medical School and completed her Internal Medicine residency at Brown University. She went on to an Ophthalmology residency at the University of Utah and a fellowship in Medical Education from Tufts School of Medicine. Her practice focuses on cataract surgery and complex anterior segment reconstruction. She is a member of the FDA Dermatologic and ophthalmic drug committee. She is internationally regarded as an expert in phacoemulsification, complex cataracts and secondary IOLs.
She has dedicated her career to teaching cataract surgery, training over 100 residents. Serving as residency director at Lahey Clinic and is a recipient of the Tufts University School of Medicine Teaching Award. She is a passionate volunteer for the mission of reducing world blindness, providing eye care in El Salvador, Egypt, Kenya, Haiti and Guatemala. Dr. MacDonald believes improving international surgical education for all ophthalmologists is an essential part of reducing world blindness.
Nick Mamalis, MD
John A. Moran Eye Center
Nick Mamalis is a Professor of Ophthalmology at the John A. Moran Eye Center of the University of Utah in Salt Lake City, Utah. He received his BA in Biochemistry from Harvard University and his Doctor of Medicine at the University of Utah, School of Medicine. He fulfilled a fellowship in Ophthalmic Pathology at the University of Utah and completed his residency in Ophthalmology at Loyola University Medical Center. He is currently the Director of Ophthalmic Pathology as well as the co-Director of the Intermountain Ocular Research Center at the University of Utah.
Dr. Mamalis is also involved in the teaching and advising of medical students, residents, and fellows. He is the Editor of the Journal of Cataract and Refractive Surgery as well as a member of the Cataract Clinical Committee of the ASCRS and the ASCRS Executive Committee. Dr Mamalis is the President Elect of the ASCRS. He also serves as the Chairman of the ASCRS Toxic Anterior Segment Syndrome (TASS) Task Force. Dr. Mamalis is a former President of the Utah Ophthalmology Society. He was given the American Academy of Ophthalmology Honor Award in 1994 and the Senior Achievement Award in 2005. Dr. Mamalis received the Life Achievement Honor Award from the American Academy of Ophthalmology in 2015. He was the recipient of the Binkhorst Medal of Honor in 2013 by the American Society of Cataract and Refractive Surgery. He has given several hundred presentations at numerous meetings nationally and internationally, as well as greater than 30 invited lectures. Dr. Mamalis has submitted and published over 200 peer review journal articles and has written multiple text books and text book chapters.
Terrence O'Brien, MD
Bascom Palmer Eye Institute at Palm Beach Gardens
Dr. O'Brien is the Director of the Refractive Surgery Service at Bascom Palmer Eye Institute at Palm Beach Gardens and the Charlotte Breyer Rodgers Chair in Ophthalmology. He is one of the world's leading experts in refractive surgery, anterior segment and eye infections. Dr. O'Brien has been selected many times as best ophthalmologists in the United States. As a visiting professor, he often conducts lectures on advances in ocular infectious diseases and prevention and management of infectious complications with refractive and other ocular surgeries.
Randall Olson, MD
John A. Moran Eye Center
Dr. Olson is the CEO at John A. Moral Eye Center and Chair of the Department Ophthalmology and Visual Sciences at the University of Utah School of Medicine in Salt Lake City. He specializes in corneal and external eye diseases and anterior segment disorders with special emphasis on all aspects of cataract surgery. He has authored more than 300 professional publications and is a worldwide lecturer. He has been honored with the American Society of Cataract and Refractive Surgery Binkhorst Lecture/Award, the American Academy of Ophthalmology Kelman Award/Lecture and will give the 2016 Jan Worst lecture for the International Intraocular Implant Club.
David J. Schanzlin, MD
Gordon Weiss Vision Institute
Dr. Schanzlin is a leading ophthalmologist, known in the field keratorefractive surgery for more than 26 years of experience. At Gordon Weiss Vision Institute he specializes in refractive and cataract surgery and anterior segment disease. He previously was a Professor and Director of Keratorefractive Surgery at the UCSD Department of Ophthalmology's Shiley Eye Center and a Director of the Anheuser-Busch Eye Institute. Dr. Schanzlin has been consistently recognized as one of the Best Doctors in America, he is a recipient of the Jose I. Barraquer Award and has made appearances on the Today Show, ABC News, Extra, and other local affiliates. Dr. Schanzlin is an innovator in his field, he is co-inventor on the patent for use of ultrashort pulse laser cataract surgery, which is designed to provide enhanced accuracy for lens implant treatments.
Dan Tran, MD
Coastal Vision Medical Group, Inc.
Dr. Tran has been in the forefront of femtosecond laser technology for ophthalmic surgery since its introduction by Intralase in 2001. He is the founder of Coastal Vision Medical Group in Orange County, CA. He has successfully served as a surgical advisor for several successful start up ophthalmic companies including IntraLase, LenSx and WaveTec Vision. His surgical expertise and engineering background have contributed to the continual improvement of ophthalmic technologies.
George Waring IV, MD
Magill Vision Center
Dr. Waring is an Associate Professor of Ophthalmology, the Director of Refractive Surgery at Medical University of South Carolina, Storm Eye Institute in Charleston and the Medical Director at Magill Vision Center in Mt. Pleasant, SC. He is also Adjunct Assistant Professor of Bioengineering at Clemson University. He is active in clinical research and specializes in cataract surgery, LASIK, refractive lens exchange and keratoconus. He has an impressive over 100 scientific publications, abstracts and presentations, lectured and taught ophthalmic surgeons worldwide advanced surgical techniques. He sits on the editorial board for numerous scientific publications including the Journal of Refractive Surgery and Cataract and Refractive Surgery Today. Dr. Waring is a recipient of both the International Society of Refractive Surgery Presidential Award and Distinguished Lans Award, the American Academy of Ophthalmology Achievement Award and has been recognized as one of the Nation's Top Doctors in Ophthalmology by Castle Connolly's Guide to America's Top Ophthalmologists.
Scientific Advisory Board Members
Josef Bille, PhD
Perfect Lens
Dr. Bille obtained his PhD from the University of Karlsruhe in 1970 in the field of physics. In 1978 he became a professor at the Institute of Applied Physics at the University of Heidelberg. Here after decades of research, he developed the use of wavefront technology which uses aberrometers to scan the human eye, creating a detailed map of errors which allows for possibility of a more precise surgical procedure. In 2012 he was awarded the Lifetime Achievement Award from the European Patent Office for his development of the wavefront technology as a measurement technology for laser eye surgery. He has been awarded an impressive over 100 patents in the field of ophthalmology and is a pioneer researcher and original inventor of femtosecond medical laser and wavefront diagnostic instruments.
In Memory of
Roger Steinert, MD (✝ 6/6/2017)
UC Irvine Faculty
Dr. Steinert was the Irving H. Leopold Professor and Chair, Ophthalmology at the University of California, Irvine School of Medicine; the director of the Gavin Herbert Eye Institute, UC Irvine School of Medicine; the vice chairman of the clinical ophthalmology at UCI; the director of refractive, cornea and cataract surgery at UCI; and professor of ophthalmology and biomedical engineering at UCI. Dr. Steinert also served on the Editorial Boards of four major journals: Ophthalmology, The Journal of Cataract and Refractive Surgery, The Journal of Refractive Surgery and Ophthalmic Surgery and Lasers. His latest research focused is the applications of femtosecond laser technology for use in corneal transplantation.